Iranian Red Crescent Medical Journal

Published by: Kowsar

The Relationship Between Coronary Artery Disease and Genetic Polymorphisms of Melanoma Inhibitory Activity 3

Hooshang Zaimkohan 1 , Mohammad Keramatipour 1 , Seyed Reza Mirhafez 2 , Javad Tavakkoly-Bazzaz 1 , Azadeh Tahooni 3 , Mohammad Piryaei 4 , Majid Ghayour-Mobarhan 2 , * and Seyed Mohammad Hossein Ghaderian 4 , *
Authors Information
1 Department of Medical Genetics, Faculty of Medicine, Tehran University of Medical Sciences, Tehran, IR Iran
2 Metabolic Syndrome Research Center, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran
3 Department of Internal Medicine, School of Medicine, Iran University of Medical Sciences, Tehran, IR Iran
4 Department of Medical Genetics, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, IR Iran
Corresponding Authors:
Article information
  • Iranian Red Crescent Medical Journal: September 01, 2016, 18 (9); e31146
  • Published Online: February 13, 2016
  • Article Type: Research Article
  • Received: July 1, 2015
  • Revised: July 3, 2015
  • Accepted: July 13, 2015
  • DOI: 10.5812/ircmj.31146

To Cite: Zaimkohan H, Keramatipour M, Mirhafez S R, Tavakkoly-Bazzaz J, Tahooni A, et al. The Relationship Between Coronary Artery Disease and Genetic Polymorphisms of Melanoma Inhibitory Activity 3, Iran Red Crescent Med J. 2016 ; 18(9):e31146. doi: 10.5812/ircmj.31146.

Abstract
Copyright © 2016, Iranian Red Crescent Medical Journal. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Materials and Methods
4. Results
5. Discussion
Acknowledgements
Footnotes
References
  • 1. Kathiresan S, Manning AK, Demissie S, D'Agostino RB, Surti A, Guiducci C, et al. A genome-wide association study for blood lipid phenotypes in the Framingham Heart Study. BMC Med Genet. 2007; 8 Suppl 1[DOI][PubMed]
  • 2. Samani NJ, Erdmann J, Hall AS, Hengstenberg C, Mangino M, Mayer B, et al. Genomewide association analysis of coronary artery disease. The New England Journal of Medicine. 2007; 357(5): 443-53
  • 3. Bosserhoff AK, Moser M, Buettner R. Characterization and expression pattern of the novel MIA homolog TANGO. Gene expression patterns : GEP. 2004; 4(4): 473-9
  • 4. Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation. 2002; 106(25): 3143-421[PubMed]
  • 5. Sandhu MS, Waterworth DM, Debenham SL, Wheeler E, Papadakis K, Zhao JH, et al. LDL-cholesterol concentrations: a genome-wide association study. Lancet. 2008; 371(9611): 483-91[DOI][PubMed]
  • 6. Saito K, Chen M, Bard F, Chen S, Zhou H, Woodley D, et al. TANGO1 facilitates cargo loading at endoplasmic reticulum exit sites. Cell. 2009; 136(5): 891-902
  • 7. Kathiresan S, Voight BF, Purcell S, Musunuru K, Ardissino D, Mannucci PM, et al. Genome-wide association of early-onset myocardial infarction with single nucleotide polymorphisms and copy number variants. Nat Genet. 2009; 41(3): 334-41
  • 8. Samani NJ, Deloukas P, Erdmann J, Hengstenberg C, Kuulasmaa K, McGinnis R, et al. Large scale association analysis of novel genetic loci for coronary artery disease. Arteriosclerosis, thrombosis, and vascular biology. 2009; 29(5): 774-80
  • 9. Maxwell KN, Breslow JL. Adenoviral-mediated expression of Pcsk9 in mice results in a low-density lipoprotein receptor knockout phenotype. Proc Natl Acad Sci U S A. 2004; 101(18): 7100-5[DOI][PubMed]
  • 10. Park SW, Moon YA, Horton JD. Post-transcriptional regulation of low density lipoprotein receptor protein by proprotein convertase subtilisin/kexin type 9a in mouse liver. J Biol Chem. 2004; 279(48): 50630-8[DOI][PubMed]
  • 11. Lalanne F, Lambert G, Amar MJ, Chetiveaux M, Zair Y, Jarnoux AL, et al. Wild-type PCSK9 inhibits LDL clearance but does not affect apoB-containing lipoprotein production in mouse and cultured cells. J Lipid Res. 2005; 46(6): 1312-9[DOI][PubMed]
  • 12. Rashid S, Curtis DE, Garuti R, Anderson NN, Bashmakov Y, Ho YK, et al. Decreased plasma cholesterol and hypersensitivity to statins in mice lacking Pcsk9. Proc Natl Acad Sci U S A. 2005; 102(15): 5374-9[DOI][PubMed]
  • 13. Humphries SE, Whittall RA, Hubbart CS, Maplebeck S, Cooper JA, Soutar AK, et al. Genetic causes of familial hypercholesterolaemia in patients in the UK: relation to plasma lipid levels and coronary heart disease risk. J Med Genet. 2006; 43(12): 943-9[DOI][PubMed]
  • 14. Kathiresan S, Voight BF, Purcell S, Musunuru K, Ardissino D, Mannucci PM, et al. Genome-wide association of early-onset myocardial infarction with single nucleotide polymorphisms and copy number variants. Nat Genet. 2009; 41(3): 334-41
  • 15. Cohen JC, Boerwinkle E, Mosley TJ, Hobbs HH. Sequence variations in PCSK9, low LDL, and protection against coronary heart disease. N Engl J Med. 2006; 354(12): 1264-72[DOI][PubMed]
  • 16. Koch W, Schatke A, Wolferstetter H, Mueller JC, Schomig A, Kastrati A. Extended evidence for association between the melanoma inhibitory activity 3 gene and myocardial infarction. Thrombosis and haemostasis. 2011; 105(4): 670-5
  • 17. Anderson JM, Cerda A, Hirata MH, Rodrigues AC, Dorea EL, Bernik MM, et al. Influence of PCSK9 polymorphisms on plasma lipids and response to atorvastatin treatment in Brazilian subjects. J Clin Lipidol. 2014; 8(3): 256-64[DOI][PubMed]
  • 18. Willer CJ, Sanna S, Jackson AU, Scuteri A, Bonnycastle LL, Clarke R, et al. Newly identified loci that influence lipid concentrations and risk of coronary artery disease. Nat Genet. 2008; 40(2): 161-9[DOI][PubMed]
  • 19. Wilson DG, Phamluong K, Li L, Sun M, Cao TC, Liu PS, et al. Global defects in collagen secretion in a Mia3/TANGO1 knockout mouse. The Journal of cell biology. 2011; 193(5): 935-51
  • 20. Mascitelli L, Pezzetta F. Statins for primary prevention of coronary artery disease. Lancet. 2007; 369(9567): 1078-9[DOI][PubMed]
  • 21. Benn M, Nordestgaard BG, Grande P, Schnohr P, Tybjaerg-Hansen A. PCSK9 R46L, low-density lipoprotein cholesterol levels, and risk of ischemic heart disease: 3 independent studies and meta-analyses. J Am Coll Cardiol. 2010; 55(25): 2833-42[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments